Central Texas Pathology Receives Accreditation

Friday, June 2, 2017 General News
Email Print This Page Comment
Font : A-A+

WACO, Texas, June 1, 2017 /PRNewswire/ -- Local pathology leader, Little River Healthcare – Central Texas Pathology

Lab, received accreditation today from the College of American Pathologists (CAP) for its recent on-site re-inspection.

The accreditation is nationally recognized as a sign of quality operations, making Waco's

LRH-Central Texas Pathology Lab one of more than 7,700 CAP-accredited facilities worldwide.

"I am extremely proud of the Central Texas Pathology Lab technical and administrative staff for their continued efforts in maintaining College of American Pathologists accreditation, which is considered a benchmark of quality," said Gary F. Geldmeier, M.D., medical director of LRH-Central Texas Pathology Lab.

Central Texas Pathology Lab offers high quality pathological readings by Texas' top board-certified pathologists committed to providing time-efficient results to patients and referring providers.

The CAP accreditation program began in the early 1960s and is designed to certify the highest standard of care for all laboratory patients. During the process, inspectors examine the laboratory's records and quality control of procedures for the preceding two years, as well as laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.

Central Texas Pathology Lab is part of the Little River Healthcare family, which operates six popular clinical locations in the Waco area, including a state-of-the-art radiology center, Little River Healthcare – Waco Imaging. To learn more about Little River Healthcare, visit LRHealthcare.com. To learn more about Central Texas Pathology Lab, visit centexpathlab.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/central-texas-pathology-receives-accreditation-300467670.html

SOURCE Little River Healthcare



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook